Anti-CD40/TNFRSF5 Antibody (PE), Mouse Monoclonal sinobiological 10774-MM17-P

$100.00
In stock
SKU
10774-MM17-P
Catalog No.SizePrice (USD)
10774-MM17-P-2525 Tests$103.68
10774-MM17-P-100100 Tests$222.17

General Information

Product nameAnti-CD40/TNFRSF5 Antibody (PE), Mouse Monoclonal
Validated applicationsFCM (FAQ Protocol)
Species reactivityReacts with: Human
SpecificityHuman CD40/TNFRSF5
ImmunogenRecombinant Human CD40 / TNFRSF5 protein (Catalog#10774-H08H)
PreparationThis antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human CD40 / TNFRSF5 (rh CD40 / TNFRSF5; Catalog#10774-H08H; NP_001241.1; Met1-Arg193) and conjugated with PE under optimum conditions, the unreacted PE was removed.
SourceMonoclonal Mouse IgG2b Clone #17
PurificationProtein A
FormulationPBS solution containing 0.5% BSA and 0.09% sodium azide
Concentration1 μl/Test, 0.1 mg/ml
ConjugatePE
FormLiquid
ShippingThis antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
StorageThis antibody can be stored at 2℃-8℃ for twelve months without detectable loss of activity. Protected from prolonged exposure to light. Do not freeze ! Sodium azide is toxic to cells and should be disposed of properly. Flush with large volumes of water during disposal.

Synonyms: Anti-Bp50 Antibody; Anti-CDW40 Antibody; Anti-p50 Antibody; Anti-TNFRSF5 Antibody

Image / Experimental Information

Image 1 DescriptionFlow cytometric analysis of human CD40 expression on human whole blood lymphocytes. Human whole blood lymphocytes were stained with PE-conjugated anti-Human CD40 and APC-conjugated anti-Human CD19(BD Pharmingen™). The histogram were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes.
Image 1 Alt TextHuman CD40/TNFRSF5 Flow Cytometry (FC) 5259
Image 1 URLSource image

Background Information

Full NameCD40 molecule, TNF receptor superfamily member 5
DescriptionCD40, also known as TNFRSF5, is a member of the TNF receptor superfamily which are single transmembrane-spanning glycoproteins. CD40 protein plays an essential role in mediating a broad variety of immune and inflammatory responses including T cell-dependent immunoglobulin class switching, memory B cell development, and germinal center formation. CD40 protein is expressed in B cells, dendritic cells, macrophages, endothelial cells, and several tumor cell lines. Defects in CD40 result in hyper-IgM immunodeficiency type 3 (HIGM3). In addition, CD40/CD40L interaction is found to be necessary for amyloid-beta-induced microglial activation, and thus is thought to be an early event in Alzheimer disease pathogenesis.
Research Areas
  • Cancer Drug Targets
Related Pathways
  • B Cell Receptor Signaling Pathway
Tags
  • Cancer Immunotherapy
  • Co-stimulatory Immune Checkpoint Targets
  • Immune Checkpoint
  • Immune Checkpoint Detection: Antibodies
  • Immune Checkpoint Detection: ELISA Antibodies
  • Immune Checkpoint Detection: FCM Antibodies
  • Immune Checkpoint Detection: ICC Antibodies
  • Immune Checkpoint Detection: IP Antibodies
  • Immune Checkpoint Detection: WB Antibodies
  • Immune Checkpoint Proteins
  • Immune Checkpoint Targets
  • Immunotherapy
  • Targeted Therapy
References
  1. van Kooten C, et al. (2000). CD40-CD40 ligand. J Leukoc Biol. 67 (1): 2-17.
  2. Bhushan A, et al. (2002). CD40:CD40L interactions in X-linked and non-X-linked hyper-IgM syndromes. Immunol Res. 24 (3): 311-24.
  3. Chatzigeorgiou A, et al. (2009) CD40/CD40L signaling and its implication in health and disease. Biofactors. 35(6): 474-83.
  4. Li R, et al. (2009) Expression of CD40 and CD40L in Gastric Cancer Tissue and Its Clinical Significance. Int J Mol Sci. 10(9): 3900-17.
  5. Lievens D, et al. (2009) The multi-functionality of CD40L and its receptor CD40 in atherosclerosis. Thromb Haemost. 102(2): 206-14.

title: Cell-Based Models of 'Cytokine Release Syndrome' Endorse CD40L and Granulocyte-Macrophage Colony-Stimulating Factor Knockout in Chimeric Antigen Receptor T Cells as Mitigation Strategy.
authors: Ala Dibas; Manuel Rhiel; ...; Toni Cathomen
journal: Cells
date: 2023-11-13
pmid: 37947658
cited_by_count: 4
techniques: Flow Cytometry
bioz_score: 92

Reviews

Write Your Own Review
You're reviewing:Anti-CD40/TNFRSF5 Antibody (PE), Mouse Monoclonal sinobiological 10774-MM17-P
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.